Cadrenal Therapeutics Inc...

NASDAQ: CVKD · Real-Time Price · USD
12.65
-0.27 (-2.09%)
At close: Aug 15, 2025, 3:08 PM

Cadrenal Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
10.02M 8.4M 32.59K
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
3.79K 3.79K -526.01K
Receivables
38.15K n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
14.45K n/a 672.29K
Total Current Assets
10.11M 8.49M 727.6K
Property-Plant & Equipment
6.94K 23.29K 44.59K
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
10.74K 27.08K 50.58K
Total Assets
10.12M 8.52M 778.17K
Account Payables
1.5M 167.32K 404.9K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
n/a n/a 43.73K
Other Current Liabilities
1.18M 596.13K 605.29K
Total Current Liabilities
2.68M 826.88K 1.33M
Long-Term Debt
n/a n/a 553.34K
Other Long-Term Liabilities
n/a n/a 4.42M
Total Long-Term Liabilities
n/a n/a 4.99M
Total Liabilities
2.68M 826.88K 6.33M
Total Debt
n/a 21.35K 640.71K
Common Stock
1.78K 13.02K 8.19K
Retained Earnings
-25.72M -15.07M -6.71M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
7.44M 7.69M -5.55M
Total Investments
n/a n/a n/a